Neurogenetics
Latest round
- Series C
Last raised
- Oct 2005
Total raised
- $62M
Investors
- 10
About Neurogenetics
Neurogenetics is a biopharmaceutical company that focuses on the development of novel small molecule therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders.
Who invested in Neurogenetics
10 investors across 4 rounds
See all investors in Neurogenetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurogenetics
Who invested in Neurogenetics?
Neurogenetics has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurogenetics raised?
Neurogenetics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurogenetics last raise money?
Neurogenetics's most recent round on record is a Series C, in Oct 2005.
What does Neurogenetics do?
Neurogenetics is a biopharmaceutical company that focuses on the development of novel small molecule therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders.
Where is Neurogenetics headquartered?
Neurogenetics is headquartered in US.
Which VCs invest in companies like Neurogenetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Neurogenetics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like Neurogenetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.